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Abstract
The ability to rapidly and safely silence the electrical activity of individual neurons or neuron
populations is invaluable in the study of brain circuit mapping. The expression of light-driven
ion channels and pumps allows these pathways to be observed, mapped and controlled with
millisecond timescale resolution. We here show that it is possible to mediate the powerful
multiple-color silencing of neural activity through the heterologous expression of light-driven
outward proton pumps and inward chloride pumps. We characterized a number of novel opsins
through an exploration of ecological and genomic diversity, and further boosted opsin function
and trafficking through the appendage of signal sequences. The green-light drivable
archaerhodopsin-3 (Arch) from Halorubrum sodomense and the yellow-light drivable
archaerhodopsin from Halorubrum strain TP009 (ArchT) are able to mediate complete neuron
silencing in the in vivo awake mouse brain, and the blue-light drivable proton pump from
Leptosphaeria maculans (Mac) opens up the potential for the multiple-color control of
independent neuron populations. Finally, the principles outlined here can be extrapolated to the
larger context of synthetic physiology.
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1. Introduction
1.1 Overview
A fundamental challenge in biology is the spatiotemporally precise study and control of complex
systems. Classical methods such as physical ablation, electrode stimulation, and genetic
knockout are crude and invasive, while exogenous ligand addition and drug delivery are spatially
imprecise due to their diffusible natures. Optogenetics, which combines molecular biology -- in
the form of genetically engineering light-drivable proteins - and optical stimulation from
sophisticated light-delivery hardware offers a tantalizing alternative. The heterologous
expression of light-drivable ion channels and pumps such as the depolarizing channelrhodopsin-
2 (ChR2)1 from the algae Chlamydomonas reinhardtil and the hyperpolarizing halorhodopsin
(halo/NpHR)2,3 from the halobacterium Natromonas pharaonis allows neural circuits to be
observed, mapped, and controlled with great spatial precision and millisecond timescale
resolution.
Although optogenetics is a young field, its scope has rapidly expanded in the past half-decade.
The ability to precisely control neural circuits has proven invaluable in understanding complex
brain modalities such as aggressionl, anxiety', autism' and drug abuse7, and physiological
processes such as cardiac arrhythmia8 and muscle fiber contractions9. Yet there is still much
room for improvement. The high-level, heterologous expression of these proteins in the
mammalian brain may lead to intracellular aggregates and possible toxicity, as well as a
significantly lower yield of functional protein. Improving opsin kinetics would extend the length
of time that neuronal populations can be silenced, as well as enabling the creation of sustained,
high-frequency neuron spike trains. Low light sensitivity is critical to the silencing of larger
brain regions, which in turn reduces the invasiveness of surgically implanted optical hardware.
Finally, creating opsins which are responsive to different light wavelengths enables the creation
of a spectral toolbox of optical sensitizers, and the multiple color control of independent neuron
populations.
This thesis presents three novel optical silencers identified through an exploratory screen of
ecological and genomic diversity, and discusses the underlying biological principles. Section 1.1
introduces the importance of optical neural control as well as some major goals and
considerations of opsin engineering. Section 1.2 describes neuron electrophysiology and the
electrophysiological techniques involved in optogenetics. Sections 1.3 discusses the larger
microbial rhodopsin families in the context of member diversity and protein structure.
Chapter 2 presents two novel optogenetic silencers, known as Arch and Mac, which function as
proton pumps rather than chloride pumps. Chapter 3 presents ArchT, an improved version of
Arch which was identified through a directed genomic screen for Arch relatives. Chapter 4
discusses some of the principles involved in developing novel optogenetic tools and the ways in
which they can be extrapolated to the larger field of synthetic physiology. Chapter 5 presents the
experimental methods. Finally, chapter 6 summarizes the presented work and proposes future
directions of study.
1.2 Neuron electrophysiology
Action potential shape and kinetics in the brain are very cell-type dependent, but some
generalizations can be made for all neurons. In its resting state, a neuron has a voltage difference
of approximately -60 mV across the cell plasma membrane (Figure 1-1) which is referred to as
the resting potential (Vrest). This voltage difference is established by ion pumps and channels
which maintain a not-insignificant number of ion concentration gradients (Table 1).
Ion Intracellular range (mM) Extracellular range (mM)
Na* 5-20 130-160
K* 130-160 4-8
Ca2+ 0.05-1.0 1.2-4
M2-+ 10-20 1-5
Cl- 1-60 100-140
HCO3- 1-3 20-30
Table 1.11 Intracellular and extracellular distribution of the main ions
found in animal fluids. (Figure adapted from Molleman 20031 0)
The tendency of ions to move with the concentration gradient, or from a region of higher
concentration to lower concentration, can be mathematically described as:
AG = -RT in [ion]extracelluiar[lon]intracellular
where AG is the Gibbs energy released by diffusion, R is the universal gas constant (-8.31 J mol'
K-), T is temperature in degrees Kelvin, and [ion]extraceiuar and [ion]imraceiar refer to the
respective extracellular and intracellular concentrations of the given ion.
Action potentials are initiated with the depolarization of a small patch of cell membrane, which
allows that region to reach a voltage threshold of approximately -50 mV (Figure 1-2). This
voltage deflection causes additional sodium channels to open. Sodium ions rapidly enter the cell
in accordance with the sodium ion concentration gradient, and the rapid influx of positive charge
causes the neuron to rapidly depolarize to 0 mV, then overshoot to a level of approximately +50
mV (Figure 1-3). Subsequently, the sodium channel gates close, and voltage-gated potassium
channels open (Figure 1-4). The cell then repolarizes, voltage briefly falling below the normal
resting potential (afterhyperpolarization) (Figure 1-5), before returning to its initial -60 mV
resting state (Figure 1-6).
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Figure 1 | A Neuron Action Potential. (1) Neuron in its resting state.
(2) Action potential initiation, cell begins to approach voltage threshold.
(3) Rapid depolarization. (4) Voltage gated potassium channels open, causing
repolarization. (5) Afterhyperpolarization. (6) Return to resting state.
Neuron voltage deflections and the corresponding action potentials (or lack thereof) are assessed
------------- -
------- ----------
in this thesis by one of two means: whole-cell patch clamp and extracellular recording.
Whole-cell patch clamping was developed by Erwin Neher and Bert Sakmarr in the late 1970s",
who later won the Nobel Prize in Physiology or Medicine in 1991 for their work. A glass
micropipette with an open tip diameter of 1-2 pm is used to approach the cell under study, and
suction is used to first create a high resistance gigaohm seal between the glass and cell
membrane, then to rupture the region of cell membrane directly in contact with the glass
micropipette opening. The glass micropipette subsequently has access to the cell cytoplasmic
space and is referred to as the intracellular electrode. Another electrode is placed in the bath
solution to serve as a ground. Recordings are then taken either in voltage-clamped mode
(measuring the amount of current which must be injected in order to maintain a constant voltage
difference across the cell membrane), or in current-clamped mode (which maintains a constant
amount of injected current while measuring voltage deflections). Both voltage- and current-
clamped recordings are standard practice within optogenetics, but this thesis primarily uses
voltage-clamped recordings to assess photocurrent. Photocurrent is here defined as the amount
of charge generated by ion influx or efflux within the cell as a result of optical stimulation.
In contrast to whole-cell patch clamp, extracellular recording measures extracellular matrix
voltage deflections generated by the current fields outside the neuron as a result of action
potentials. The activity of one or multiple neurons may be recorded, depending on electrode tip
size and local neuron density, and referred to respectively as "single-unit" or "multi-unit"
recordings. While the obtained data has a significantly smaller signal than whole-cell patch
clamp, extracellular recording can be conducted in vivo on awake, restrained animals. Further,
extracellular recordings can be used to simultaneously determine the signaling state of a neuron
population, rather than that of individual cells, and recordings can be carried out for much longer
time durations without the time limits cell dialysis imposes on whole-cell patch clamp.
1.3 Microbial opsins
While all members of the opsin superfamily share a highly characteristic seven transmembrane
alpha-helical structure and retinal chromophore attached to a conserved lysine residue (Figure 2),
primary sequence alignments divide them into two independent protein families: the type 1
opsins which play a role in phototaxis and light-driven ion transport in both eukaryotic and
prokaryotic microbial species, and the type 2 opsins, which mediate vision and circadian rhythms
in higher eukaryotes. At present, it is unknown whether the two families descend from a single
progenitor ancestor or whether they are the product of convergent evolution 2 . The presence of
type 1 opsins among organisms as diverse as archaea, bacteria, and fungi may either be the result
of a shared common ancestor, or horizontal gene transfer within the haloarchaea.
Functionally, type 1 microbial opsins can be divided into transporters and receptors.
Bacteriorhodopsin, one of the most extensively studied of all opsins, was identified by Oesterhelt
and Stoeckenius in 1971 '4 from the archaeal Halobacterium halobium and soon determined to be
a light-dependent proton pump'. Subsequent work was carried out in Halobacterium to identify
similar light-sensitive proteins and halorhodopsin1'6 17 8, sensory rhodopsin 119,20,21,22 and sensory
rhodopsin II23,24,25,26,27,28 (also known as phoborhodopsin) were isolated and characterized over
the next two decades. Of these, bacteriorhodopsin and halorhodopsin are transporters -- ion
pumps which respectively generate proton electrochemical potentials for ATP production and
hyperpolarize the cell membrane via chloride transport -- and the sensory rhodopsins serve as
"visual" photoreceptors for microbial phototaxis in low oxygen environments.
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Figure 2 | Natromonas pharaonis halorhodopsin structure. Schematic of the
classic seven-transmembrane helix opsin structure. (Figure adapted from
Kouyama et al. 201029)
Extensive structural work has been conducted on the type 1 microbial opsins. Electron
crystallographic analyses of bacteriorhodopsin were carried out by Henderson and Unwin to a
resolution of 7 A as early as 197530. This work was later improved on, yielding a number of
electron and x-ray crystallography structures 31,32 ,33,34 ,35 , culminating in the 1.6 A structure
reported by Luecke and colleagues in 199936. High resolution structures of halorhodopsin have
also been obtained for the Halobacterium salinarum strain in 200037,3' and for the Natromonas
pharaonis strain in 201029. Finally, sensory rhodopsin II has additionally been crystallized 39.
Remarkably, the helix architecture is highly conserved among all four types of type 1 microbial
opsins from the same organism, and additionally within orthologs, suggesting a potential
underlying architecture that can be engineered across all microbial opsins.
2. Mining Opsin Phylogenetic Diversity
The work outlined in this chapter resulted in the publication of "High-performance genetically
targetable optical neural silencing by light-driven proton pumps" in Nature (2010) by Brian
Chow and colleagues4 0. My contribution to this project was in the area of gene cloning, virus
making, and cell culture transfection.
2.1 Engineering Halo
The heterologous expression of the Natromonaspharaonis halorhodopsin (halo/NpHR) in
neurons to achieve light-drivable silencing represented a major stride forward for the
burgeoning field of optogenetics. A hyperpolarizing complement to the depolarizing ChR2 now
existed for the first time, allowing the transient silencing of neuron populations and enabling
bidirectional signaling within the same cell (Figure 2).
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Figure 3 1 Single-cell bidirectional signaling using stoichiometric co-
expression of Halo and ChR2. (A) Overlaid peak-normalized action spectra for
ChR2 and Halo. (B) Hyperpolarization and depolarization events elicited in a
single representative neuron by blue and yellow light pulse trains. (Figure
adapted from Han et al 200941)
Yet despite its great in vitro promise, Halo still has a number of problems which needed to be
solved for in vivo implementation. When expressed at high levels, such as those seen with high
titer virus or in transgenic mice, Halo forms puncta and intracellular blebs (Figure 4).
Figure 41 Poor membrane expression and intracellular blebbing in Halo transgenic
mice. NpHR-YFP forms numerous intracellular blebs in neurons of Thyl-NpHR-YFP
transgenic mice. Scale bars: 100 pm. (Figure adapted from Zhao et al. 20084')
Additionally, Halo's pumping activity -- and with it, its ability to silence neurons -- runs down
and the protein inactivates during long periods of illumination (Figure 5). While this
phenomenon can be addressed via blue-light resets, there are many situations in which it may not
be experimentally desirable to have two optics sources. Additionally, it would be advantageous
to boost the single-molecule efficacy of Halo, as this would enable the more powerful silencing
of individual neurons, and additionally the silencing of much larger brain regions.
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Figure 5 1 Halo inactivation during sustained periods of illumination. Time-
course of Halo-mediated hyperpolarizations in a representative current-clamped
hippocampal neuron during 15 seconds of continuous yellow light, followed by
four 1 second test pulses of yellow light (one every 30 seconds, starting 10
seconds after the end of the first 15-second period of yellow light. (Figure
adapted from Han & Boyden 20072)
In order to improve upon Halo, we screened a number of trafficking sequences and point mutants
in HEK 293FT cells to see if it was possible to achieve spectral shift or to generate a Halo
mutant which could spontaneously recover its active pumping state in the dark over a second
timescale without blue-light illumination (Table 2). 'Recovery' residues were targeted based on
hypothesized roles in chloride affinities and/or transport kinetics, as determined by structure-
function studies and mutagenesis studies using other halorhodopsins 42,43,44,4 . Spectral residues
were targeted based upon their predicted retinal flanking locations based on crystal structures,
37,46,47,48,49,50
and/or have been previously shown to govern the bacteriorhodopsin spectrum''
Halo Homologous Homologous Primary Primary Peak i Recovery
point H. salinarum H. salinaruim predicted FWHM (nm), of active
mutant HR residue BR residue outcome of second order pumping
mutation Gaussian fit in dark?
Wild type N/A N/A N/A 584 51 No
T126H T111 D85 Recovery No measured No
T126R T111 D85 Recovery No measured No
potocurrent
W127F W112W86 Spectral No measured No
shift hotourrent
S130T S130 T89 Recovey 568± 55 No
S130D S130 T89 Recovery No measured No
otocurrent
SI3IH S130 T89 Recovery No measured No
S130R S130 89 Recovery No measured No
A137T A122 D96 Recovery 585 52 No
A137D A122 D96 Recovery 57553 No
A137H11219 ecvr No measured No
photocurrent _
A137R A122 D96 Recovery No measured No
photocurrent
G163C 1G148 G122 Spectral No measured No
shift hotocurrent
W179F W164 W137 Spectral No measured I No
shift hotocurrent
S183C F168 S141 Spectral No measured No
shift p ourent
F187M F172 M145 Spectral 589±52 No
shift
F187A F172 M145 Spectral No measured No
shift photocurrent
K215H R200 R149 Recovery 586+50 No
K215R R200 R149 Recovery 575 51 No
K215Q R200 R149 Recovery 585+56 No
~T18S |T203 TRecovery 582 ± 53 No
T218D 203 T178 Recovery No measured No
photocurrent
T218H T203 T178 Recovery No measured No
photocurrent
I ' __L
Halo Homologous Homologous Primary Primary Peak Recovery
point H. salinarum H. salinarum predicted FWHM (nm), of active
mutant HR residue BR residue outcome of second order pumping
mutation Gaussian fit in dark?
T218R T203 T178 Recovery No measured No
photocurrent
SW207 W82 Spectral No measured No
shift - 1phtocurrent
P226V P211 P186 Spectral No measured No
shift photocurrent
P226G IP211 P186 Spectral No measured No
shift photocurrent
W229F W214 W189 Spectral 587 53 No
shift
Table 21 Action spectrum and spontaneous recovery to active pumping state
in the dark for N. pharaonis halorhodopsin point mutants examined in
HEK293FT cells. (Table adapted from Chow et al. 2010")
We additionally screened a number of signal sequences from the MHC Class I antigen (ss')52,
prolactin ('prl') 53, and an ER export sequence from the potassium channel Kir2.1 ('ER2') 41' 54 t
see if it was possible to improve Halo photocurrents and trafficking. While photocurrents did
improve relative to the wildtype, presumably through improving functional protein yield, we did
not observe changes in Halo spectral shift or photorecovery (data not shown).
For these reasons, we thought it would be advantageous to mine genomic diversity to see
whether other opsins existed which naturally possessed the properties of interest.
2.2 Phylogenetic opsin screening
We screened a total of seventeen type I microbial opsins (Table 3) from archaebacteria, bacteria,
plants, and fungi to identify light-driven hyperpolarizers which had improved photocurrents and
action spectra. Mammalian codon-optimized genes were synthesized, cloned into GFP-fusion
expression vectors under the CamKII promoter, and transfected into primary hippocampal or
cortical neuron cultures. Opsin photocurrents were measured via whole-cell patch clamp, and
additionally reported as photocurrent densities by normalizing for cell-capacitance as a measure
of cell size, and spectrum normalized photocurrent densities by adjusting for different opsin
spectral peaks (Figure 6).
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densities (right y axis, white bars), measured by whole-cell patch-clamp of
cultured neurons under screening illumination conditions (575 25 nm, 7.8
mW/mm2 for all except Mac/LR/Ops, gPR, bPR and Ace/AR, which were 535
25 nm, 9.4 mW/mm 2 ; n=4-16 neurons for each bar). Data are mean and s.e. Full
species names from left to right: Natronomonaspharaonis2,3,5 , Halobacterium
salinarum55' 56, Halorubrum sodomense5 6, Halorubrum species ausS-5 -S,
Haloarcula vallismortis58' 5 9 , Haloarcula marismortuie9', Haloquadratum
walsbyi61 , Haloterrigena species Arg-4 '59, Salinibacter ruber62 63, Podospora
anserina", Neurospora crassa65 , Leptosphaeria maculans66, Halorubrum
sodomense56, Halobacterium salinarum55 ,56, Haloarcula species Arg-167,
uncultured gamma-proteobacterium BAC31A8 68,69, uncultured gamma-
proteobacterium Hot75m4 and Acetabularia acetabulum70 . (Figure adapted
from Chow & Han et al. 201051)
Abbreviations Molecule class Species of origin GENBANK References
Accession
Halo, NpHR, halorhodopsin
sHR, HR halorhodopsin
aHR-3 archaehalorhodopsin
aHR-1, SGHR archachalorhodopsin
cHR-3 cruxhalorhodopsin
cHR-5 cruxhalorhodopsin
SquareHOP square halorhodopsin
Natronomas
pharaonis
Halobacterium
salinarum
Halorubrum
sodomense
Halorubrum aus-1
(sp. SG1)
AD 05Oo
BQz
NP_279315
BAA75202
CAA49773
Haloarcula BAA06679
vallismortis
Haloarcula AAV46572
marismortui
Haloquadratum
walysbyi
CAJ53165
:x)
58,59
61
50
dHR-1 deltahalorhodopsin Hato rr a BAA75201
Arg-4
SaIHO,
SRU_2780
bacterial
halorhodopsin
Salinibacter ruber AAT76430 0*
POp fungal opsin related Podospora XP_00042
protein anserina (DSM980) 82
nop-1 fungal opsin related Neospora crassa XP959421
protem
Mac, LR, Ops Fungal opsin related Leptosphaeria AAGO 1180
protein, maculans
bacteriorhodopsin
Arch, aR-3 archaehodopsin Halorubrum BAA09452
sodomense
BR Bacteriorhodopsin Halobacterium CAA23744
salinarum
cR-1 Cruxrhodopsin Haloarcula BAA06678
argentinensis (sp.
arg-I
gPR, BAC31A8 Proteorhodopsin y -proteobacterium AAG10475
BAC31A8
bPR, Hot75m4 proteorhodopsin 7-proteobacterium 7Q9AF
Hot75m4
Ace, AR Algal Acetabularia AAY82897
bacteriorhodopsin acetabulum
Table 3 | Summary of molecular screening candidates, including
abbreviations, molecule classification, species of origin, GenBank accession
number, and references.
Of these constructs, the putative proton pump archaerhodopsin-3 from H.
sodomense (Arch/aR-3)7 ' generated the highest photocurrents. Two other proton
pumps, the Leptosphaeria maculans opsin (Mac/LR/Ops) 66 and cruxrhodopsin-167
also had significantly larger photocurrents than the Natromonas pharaonis
halorhodopsin. All of the assessed light-driven proton pumps had higher screen
photocurrents than the light-driven proton pumps.
We assessed Arch and Halo membrane expression using confocal microscopy and found that
Halo and Arch possessed similar absolute expression levels on the cell plasma membrane5.
Unlike Halo, Arch traffics well to the cell membrane without signs of intracellular aggregates
(Figure 7).
Figure 7 1 Confocal fluorescence image of a lentivirally infected cultured
neuron expressing Arch-GFP under the CamKII promoter.
Arch-mediated currents exhibited excellent kinetics of light-activation (8.8 ± 1.8 ms, n=16) and
post-light-recovery (19.3 ± 2.9 ms, n=16). Unlike the wildtype Halo and Halo mutants, Arch
spontaneously recovered light function within a timescale of seconds (Figure 8), and
demonstrated a significant dynamic range. At low light irradiances of 0.35 and 1.28 mW/mm2
(Figure 9i), neural currents were 120 and 189 pA, respectively; at higher light powers (at which
Halo currents saturate), Arch currents continued to increase, approaching 900 pA at effective
irradiances of 36 mW/mm 2 (Figure 9ii).
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Figure 8 | Arch spontaneously recovers pumping post-illumination. Top half
shows raw current trace of a neuron lentivirally infected with Arch, illuminated
by a 15-s light pulse (575 ± 25 nm, 7.8 mW/mm 2 ) followed by 1-s test pulses
delivered at 15, 45, 75, 105 and 135 s after the end of the 15-s light pulse.
Bottom half of graph shows population data of averaged Arch photocurrents
(n=1 1 neurons) sampled at the times indicated by the vertical dotted lines.
(Figure adapted from Chow & Han et al. 201051)
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Figure 9 1 Arch has significantly greater dynamic range than Halo.
Photocurrents of Arch versus Halo measured as a function of 575 ±25 nm light
irradiance in patch-clamped cultured neurons (n = 4-16 neurons for each point),
for low (left) and high (right) light powers. The line is a single Hill fit to the data.
(Figure adapted from Chow et al. 201051)
2.3 Arch implementation in the in vivo rodent brain
We first estimated the tissue volumes which could be silenced, using in vitro culture data to
estimate photocurrents for different irradiances and computational Monte Carlo simulations
(Figure 10). We chose 0.35, 1.28, and 6 mW/mm 2 in order to simulate irradiance at 1.7, 1.2, or
0.6 mm away from the tip of a 200 pm fiber emitting 200 mW/mm2, and measured the reduction
in spike rate for each condition. Arch expressing neurons were significantly more inhibited than
eNpH R-expressing cells, suggesting a 10-fold increase in brain tissue volume that would be
~50% silenced.
Irradiance contours at 100, 10, 5, 2.4, 2, 1, and 0.6 mW/mm 2
0 500 1000
Distance from Fiber Surface (microns)
1500
Figure 10 | Irradiance contours for 593 nm yellow light in the brain. 593 nm
light is plotted as a function of location with respect to the top of a 200 pm fiber
emitting 200 mW/mm 2 at the fiber tip into gray matter. Light irradiance was
estimated using a Monte Carlo light scattering/absorption simulation. (Figure
adapted from Chow et al. 201051)
To directly assess Arch's behavior in vivo, we injected encoding for Arch under the CamKII
promoter into the mouse cortex and recorded neural responses -1 month later via extracellular
recording. We recorded neurons in awake head-fixed mice, illuminating neurons with a 200-pm
optical fiber coupled to a 593 nm laser. The firing rate of many neurons immediately and
strongly declined after light onset, and remained low throughout the illumination duration for
both brief (Figure 11a, top) and long durations (Figure 11a, bottom).
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Figure 11 | High-performance Arch-mediated optical neural silencing of
neocortical regions in awake mice. (A) Representative extracellular recordings
showing neurons undergoing 5-s, 15-s, and 1-min periods of light illumination.
(B) Neural activity in a representative neuron before, during, and after 5 s of
yellow light illumination, shown as a spike raster plot (top) and as a histogram of
instantaneous firing rate averaged across trials (bottom; bin size, 20 ms). (C)
Population average of instantaneous firing rate before, during and after yellow
B
C
7
light illumination (black line, mean; gray lines, mean + s.e.; n= 13 units). (D)
Average change in spike firing during 5-s of yellow light illumination (left) and
during the 5 s immediately after light offset (right), for the data shown in B. (E)
Histogram of percentage reductions in spike rate, for each individual neuron,
integrated across all 5-s silencing periods.
We recorded 13 single-units that showed any decrease in firing during illumination and found
spiking rates during exposure to 5 seconds of yellow light (Figure 11b) to drop by an average of
90 : 15% (mean + s.d.; Figure 11c, d) and restoring to levels indistinguishable from the baseline
after light cessation (P>0.2, paired t-test; Figure 11d). Six of the 13 units decreased spike rate
by at least 99.5%, and the median decrease was 97.1% (Figure 11e). One possibility is that
Arch-expressing cells were almost completely silenced, whereas non-infected cells also
decreased activity owing to network activity reduction during illumination.
The kinetics of silencing were rapid: for the six neurons that underwent >99.5% silencing, spike
firing reduced with near-0-ms latency, rarely firing spikes after light onset; averaged across all
cells, firing-rate reductions plateaued within 229 ± 310 ms (mean ± s.d.) after light onset. After
light cessation, the initial firing rate rapidly restored itself for the highly silenced neurons;
averaged across all cells, firing rates took 355 ± 505 ms to recover after light offset. The level of
post-light firing did not vary with repeated light exposure. Thus, Arch can mediate reliable
silencing of neurons in the awake mammalian brain.
2.4 Multiple-color control of independent neuron populations
Great spectral diversity can be found in the proton pumps, in contrast to chloride pumps, which
are primarily driven by yellow-orange light. The light-driven proton pump Mac in our screen
had an action spectrum strongly blue-shifted relative to the light-driven chloride pump Halo
(Figure 12a). We found that Mac-expressing neurons undergo four-fold larger
hyperpolarizations with blue light than with red light, while Halo-expressing neurons undergo
three-fold larger hyperpolarizations with red light than with blue (Figure 12b). Accordingly, we
were able to demonstrate selective neural silencing in Mac-expressing neurons in response to
blue light, and selective silencing of spike-firing in Halo-expressing neurons in response to red
light (Figure 12c). It is clear that the spectral diversity of proton pumps enables the possibility
of independent multicolor silencing of separate neural populations.
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Figure 12 Multicolor silencing of two neural populations, enabled by blue-
and red-light drivable ion pumps of different classes. (A) Action spectra of
Mac versus Halo; rectangles indicated filter bandwidths used for multicolor
silencing in vitro. Blue light is delivered by a 470 ± 20 nm filter at 5.3 mW/mm 2
and red light is delivered by a 630 ± 15 nm filter at 2.1 mW/mm 2 . (B) Membrane
hyperpolarizations elicited by blue versus red light, in cells expressing Halo or
Mac (n = 5 Mac expressing and n=6 Halo-expressing neurons). (C) Action
potentials evoked by current injection into patch-clamped cultured neurons
transfected with Halo (top) were selectively silenced by the red light, but not by
the blue-light and vice-versa in neurons expressing Mac (Middle). Grey boxes in
the inset (bottom) indicate periods of patch-clamp current injection. (Figure
adapted from Chow et al. 201 051)
2.5 Discussion
Arch and Mac represent members of a new, diverse and powerful class of optical neural
silencing reagent: the light-driven proton pump. The efficacy of these proton pumps is
surprising, given that protons occur at a million-fold lower concentration in mammalian tissue
than the ions carried by other optical control molecules.
Extensive work has been done in the optogenetic field with the goal of engineering opsin
structure to obtain certain properties. However, this work suggests that a much simpler
alternative may be mining ecological and genomic diversity to find naturally-occurring
molecular reagents. These opsins may possess desirable properties difficult to engineer, such as
the proton pumps' spontaneous recovery after optical activation, and their wide diversity lends
itself to spectral diversity which would enable the multiple-color control of independent, discrete
neuron populations. Further, structure guided mutagenesis of Arch and Mac may further
facilitate the development of neural silencers with altered spectrum or ion selectivity, and lends
itself to a better understanding of proton pumps, as well as the larger opsin family.
3. ArchT: a novel, high-light sensitivity neural silencer
The work outlined in this chapter resulted in the publication of "A High-Light Sensitivity Optical
Neural Silencer: Development and Application to Optogenetic Control of Non-Human Primate
Cortex" in Frontiers in Systems Neuroscience (2011) by Xue Han and colleagues72. My
contribution to this project was in the area of gene cloning, virus making, cell culture
transfection, and assessing the effect of different protein trafficking sequences.
3.1 Engineering Arch
In our previous work, we found that the light-driven outward proton pump archaerhodopsin-3
(Arch) was capable of mediating strong, reliable, and safe neural silencing in response to green-
yellow light, likely due to its good functional expression in neurons, fast photocycle, rapid post-
illumination recovery kinetics, and the excellent proton handling capability of neurons4". We
next embarked upon a number of strategies to improve Arch including targeted residue
mutagenesis, the addition of trafficking sequences, and additional phylogenetic screening. While
targeted mutagenesis either significantly reduced or did not alter Arch photocurrents (data not
shown), we explored the neural silencing capability of opsins with a high sequence homology to
Arch, cloned from various archeal species within the Halorubrum genus. All electrogenetic
members of this opsin class, known as archaerhodopsins, expressed cleanly and well on the
neuron cell plasma membrane and demonstrated large hyperpolarizing currents when expressed
in primary rodent neuron culture (Figure 13).
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Figure 13|I Archaerhodopsin screen photocurrents. Screen photocurrents
generated by various opsins within the archaerhodopsin class, as assessed in
neuron culture (n = 5-16 neurons for each bar), measured by whole-cell voltage
clamp under 7.8 mW/mm 2, 575±25 nm illumination. Full names from left to
right: archaerhodopsin from Halorubrum strain aus- 1 (aR-1), archaerhodopsin
from Halorubrum strain aus-2 (AR-2), archaerhodopsin from Halorubrum
sodomense (Arch), archaerhodopsin from Halorubrum strain xz5 15 (aR-4),
archaerhodopsin from Halorubrum strain TPO09 (aR-TPO09, aka ArchT),
archaerhodopsin from Halorubrum xingjianense (aR-BD 1). (Figure adapted
from Han et al. 20117)
Like Arch, all of the screened archaerhodopsins exhibited rapid photocurrent rise and fall
kinetics during illumination, as well as good post-illumination recovery (data not shown). All of
the archaerhodopsins exhibited similar action spectra to that of Arch and were proton pumps as
evidenced by photocurrent in the absence of sodium, potassium, calcium and chloride ions. The
archaerhodopsin from Halorubrum strain TPO09, which we named ArchT, had the highest of all
screened photocurrents. Although Arch and ArchT have highly similar sequences which are
homologous by 91.9% (Figure 14), ArchT has an action spectrum slightly red-shifted relative to
Arch and exhibits a 3.3-fold increase in light sensitivity over Arch (Figure 15), with a similar
maximum current to Arch (~900 pA in vitro) and similar photocurrent rise and fall kinetics.
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Figure 14 | Arch and ArchT have significant sequence homology. Alignment
was done using the ClustalW2 pairwise sequence algorithm created by Thompson
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Figure 15 1 ArchT is a novel, high-light sensitivity optical neural silencer.
Photocurrents of Arch and ArchT measured as a function of 575 ±25 nm light
irradiance (n = 4-16 neurons for each point); curves are Hill plots. (Figure
adapted from Han et al. 201172)
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We did not examine irradiances greater than 36.3 mW/mm2 (the rightmost datapoint in Figure
15), but we would expect a similar maximum degree of inhibition between neurons expressing
Arch and ArchT, but a significantly larger silenced brain volume with ArchT given that
irradiances as higher as 200-500 mW/mm2 are used in vivo. According to our earlier
computational models (Figure 10), a three-fold improvement in light sensitivity would increase
the tissue volume addressed by a typical single optical fiber two-fold, making ArchT of instant
utility for silencing larger brain volumes. From this, we concluded that ArchT could mediate
fast hyperpolarization of neurons with excellent light sensitivity.
3.2 ArchT implementation in the in vivo rodent and primate brain
We next made ArchT lentivirus, targeting expression to cortical pyramidal neurons of the murine
brain under the CamKII promoter. We found that ArchT trafficked well to the cell membrane
and, additionally, expressed rapidly and well along axonal projections traveling far from the cell
body, suggesting possible utility in silencing defined projection pathways between different brain
regions.
Encouraged by ArchT's high-light sensitivity and good trafficking, coupled with the success of
earlier optogenetic non-human primate experiments74, we used the aforementioned lentivirus to
genetically target ArchT to cortical pyramidal neurons of the cortex of the rhesus macaque.
Histological examination of ArchT-expressing neurons in cortical tissue from one monkey
showed that neurons appeared healthy and expressed ArchT well at a timepoint 1 month after
viral injection (data not shown). When cortical neurons in a second monkey were recorded
during illumination with a fiber coupled to an inexpensive 532 nm laser (fiber tip irradiance 100-
200 mW/mm 2) 1-3 months after viral injection, clear ~100% light-mediated silencing of neural
activity was observed in the majority of recorded cells (Figure 16a, b) with a median resultant
firing rate of 0 spikes/s among the neurons which showed any decrease in firing upon light
delivery (Figure 16c).
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Figure 16 1 ArchT-mediated silencing of cortical neurons in the awake
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primate brain. (A) Neural activity in a representative silenced neuron in the
primate brain before, during and after 1 s of green light illumination. Neural
activity shown as a spike raster plot (top), and as a histogram of instantaneous
firing rate averaged across trials (bottom; bin size 20 ms). (B) Histogram of
instantaneous firing rate, averaged across all silenced single units recorded upon 1
s green light exposure either using raw firing rate data (top) or using firing rate
data normalized to baseline firing rate (bottom). (C) Histogram of peak
percentage reductions in spike rate, for each individual silenced neuron. (Figure
adapted from Han et al. 201172.)
Interestingly, 7 of the 74 recorded neurons did not show reductions in firing rate during
illumination but instead underwent significant increases in spiking activity during light-delivery
to ArchT expressing pyramidal neurons. These cells increased their firing rate by a median of
2.9 fold (range 2.0- to 10.6-fold; Figure 17). These neurons began spiking with a latency of 280
ms after light onset, significantly longer than the latency for initiating optical quieting of the
primary population of light-silenced neurons (p<0.01, Mann-Whitney U-test). These increased-
activity neurons were recorded at locations that were interspersed amongst the locations where
silenced neurons were recorded.
AN
I25
0
B
n=7 neurons
F
20
10
0 
-- - ----
-2 -1 0 1 2 3 4 5 6
Time (s)
*.L12
0 8
4
0
e -2 -1 0 1 2 3 4 5 6
Time (s)
Figure 17 ArchT silencing causes a firing-increase in a small percentage of
neurons. (A) Neural activity, shown as a spike raster plot (top) and as a
histogram of instantaneous firing rate averaged across trials (bottom; bin size 20
ms). (B) Histogram of instantaneous firing rate, averaged across all increased-
activity single units recorded upon 200 ms green light exposure, either using raw
firing data (top) or using firing rate data normalized to baseline firing rate
(bottom). Black line, mean; gray lines, mean ± standard error; n=7 increased
activity single units. (Figure adapted from Han et al. 201172.)
We used spike waveform shapes to analyze the cell-type identity of the silenced and increased-
activity neurons. Six of the 45 silenced neurons had narrow spike waveforms with trough-to-
peak durations of 100-200 microseconds, suggestive of putative inhibitory neurons, whereas the
remainder had broader spike waveforms, suggestive of putative excitatory neurons'5. Three of
the seven increased-activity neurons had narrow spike waveforms, suggestive of inhibitory
neurons7 5 . Thus, it is likely that both the silenced and increased-activity populations of neurons
comprised mixed populations of pyramidal cells and inhibitory cells.
3.3 Discussion
We here present a novel optical neural silencing tool that expresses well on the neuron cell
membrane, with good axonal expression, and operates well in the context of the awake
mammalian brain. Like Arch, ArchT supports light-driven quieting of neural activity with high
efficacy and fast kinetics, utilizing inexpensive 532 nm lasers for illumination. The key
difference is that ArchT has >3x improved light sensitivity relative to Arch at lower light powers
from 1-10 mW/mm2 , something of critical importance for silencing large brain volumes with a
single fiber: a system in which light falls off rapidly and geometrically.
4. Synthetic Physiology: Strategies for Adapting Tools From Nature
This chapter was published elsewhere as "Synthetic physiology strategies for adapting tools from
nature for genetically targeted control of fast biological processes" in Methods in Enzymology
(2011) by Brian Chow, myself, Nathan Klapoetke and Edward Boyden'.
4.1 Molecular design and construction
We here identified a number of opsins from genomic databases by searching for proteins with
similar amino acid sequence homology to previously characterized opsins. This method can be
extrapolated to the larger goal of developing synthetic physiology tools. A number of microbial
opsins have been identified at a genomic level in the forty years since the class was first
identified, yet only a subset of these molecules have been characterized at a physiological level.
De novo gene synthesis has proven important for rapid construction of opsin DNA from
sequences derived from genomic and transcriptomic databases2,40. One can obtain a gene codon-
optimized to the target organism 77'7879 within a few days to weeks of sequence identification.
Codon optimization is useful for heterologous expression of these genes, which are originally
isolated from algae, bacteria, and other non-animal species. De novo gene synthesis additionally
allows the elimination of restriction sites within the gene to ease later molecular cloning steps,
for example, by enabling fusion of a fluorescent protein tag to the molecule, adding trafficking
sequences, or adding a cell type-specific promoter to the gene to delimit the expression to
specific cells within the target organism.
After gene synthesis, the next step is to alter the gene as needed, or to append extra sequences to
optimize its function toward a directed physiological control goal. A few opsin crystal structures
have been obtained80 ,3 7,36,81 ,82,83 and decades of studies have been performed in which specific
residues within opsins were mutated, followed by spectroscopic or physiological characterization
of the resultant mutated opsins8 4' 49-50' 85' 4 '47' 86'87'88'89'90'51. These datasets have proven influential
in guiding the strategic engineering of these molecules through site-directed
mutagenesis 91,92,93,40,94 , enabling the creation of molecules with improved trafficking, or faster or
slower kinetics. Antibodies for localizing many of these opsins in an immunocytochemical
fashion are not yet commonly available, so tagging the proteins with a fluorophore or a known
antibody epitope is helpful to efficiently determine which cells within the target organism are
expressing the opsin. Such tagging additionally yields critical information about the membrane
trafficking and localization of opsins within cells - indeed, fluorophore localization to the plasma
membrane of opsin-fluorophore fusions has been used to predict photocurrent magnitude, as
measured through electrophysiology characterization 93.
We have previously reported a method for quantifying membrane localized proteins in neurons 0 ,
based on a Gaussian-blur-based technique developed for the same purpose in HEK293 cells93.
This method is useful for quantifying protein localization in the cells, but it does not provide
information on whether the protein is properly folded and functional within the membrane.
Ultimately it is the number of functional proteins in the membrane which determines their
overall physiological control efficacy. Since these molecules, when expressed in neurons or
other animal cells, are often in a very different lipid environment than the one they evolved to
function in, even a properly folded molecule in a lipid membrane may not be fully functional.
As a concrete example, photocurrent enhancement of an opsin by appending the flanking
sequences of the KiR2.1 protein95 boosts the membrane expression of opsins as observed through
microscopy, but may boost the photocurrent even more than might be expected from the cellular
appearance alone: this appearance-current discrepancy may vary from opsin to opsin. Indeed,
KiR2.1 sequences may even decrease overall cellular expression for some opsins, even as it
increases the amount of properly folded functional membrane-embedded protein. Thus,
quantitative confocal microscopy must be supplemented by a functional, physiological assay.
This theme -- that there are few proxies for function in the assessment of synthetic physiology
tools -- is partly why they are hard to find, engineer, and assess.
It is important to realize that the complexity of these molecules means that even an innocuous
change like creating a fusion protein between an opsin and a fluorophore may modulate the
function of the opsin. Several laboratories have observed that fluorophore fusions with a target
molecule can alter performance of the target molecule by altering viral titer96. Appending
different fluorophores (e.g., EGFP vs. mCherry vs. ECFP) to an opsin can result in different
appearances (e.g., due to mCherry's greater tendency to aggregate than EGFP or ECFP) and
potentially different photocurrent for a given cell type. In the event that fusion of a fluorophore
to a given opsin is undesirable, alternatives exist to directly fusing fluorophores to opsins, while
still enabling identification of cells expressing the opsin, including interposing IRES (internal
ribosome entry sites) or 2A sequences ('self-cleaving' linkers first identified in foot-and-mouth-
disease virus) between opsins and fluorophores. Protein expression levels for the gene that
appears after the IRES is often a small fraction of that of the gene before the IES97'98'99'100. 2A
sequences in principle yield highly stoichiometric amounts of translated protein, but in reality,
different functional levels may be observed for the pre- and post-2A proteins, due to alterations
in protein trafficking or function that result from the residual amino acids of the 2A sequence left
behind after protein translation41.
The use of trafficking sequences, export motifs, and other signal sequences is useful for
improving the heterologous expression of opsins in the cells of target organisms, since the
function of opsins in neurons is primarily achieved when opsins express on the plasma
membrane. Practically all opsins come from organisms whose membrane structure and overall
cellular architecture is different from neurons. For example, N. pharaonis halorhodopsin
photocurrents can be enhanced several fold in mammalian cells by appending the N- and C-
terminal sequences of the human KiR2.1 potassium channel protein, which are responsible for
endoplasmic reticulum-export and Golgi-export (although, see alternative explanations of the
role that these KiR2.1 sequences play in boosting cellular expression, above)' 02"03,104,95. The
enhancement offered by a given exogenous trafficking sequence is opsin-dependent. A
trafficking sequence that boosts N. pharaonis halorhodopsin expression levels (the ER2
sequence 54) has no effect on improving the currents of the H. sodomense archaerhodopsin-3,
although adding a different sequence (the Prl sequence, derived from the prolactin secretion
targeting sequence) does improve archaerhodopsin-3 expression and photocurrent 0 . Through
experimenting with combinatorial addition of N- and C-terminal signal sequences, we have
found adding multiple signal sequences does not necessarily improve expression in a linear way,
perhaps owing to interactions between the multiple trafficking mechanisms at play. It should be
noted that opsins may also possess intrinsic, even covert, sequences that enable them to be
expressed very well on the plasma membrane. For example, the light-driven outward proton
pump archaerhodopsin-3 from H. sodomense (and, in general, members of the archaerhodopsin
class of opsins) naturally expresses rapidly and well on plasma membranes40 . Opsin mutagenesis
and chimeragenesis has pointed towards candidate amino acids that may play a critical role in
opsin trafficking and expression on the plasma membrane92 ,93
4.2 Transduction of microbial opsins into cells for heterologous expression.
The analysis of the potential power of a given microbial opsin to control the voltage or ionic
composition of a target cell type should ideally be performed in the target cell type itself, or in a
testbed cell type as similar as possible to the target cell type. For example, the trafficking-
enhancement and protein folding enhancement sequences described above are derived from
specific species, and were optimized in cells from specific species; accordingly, they may not
work equally well in species different from the source species, or in cell types greatly different
from the cell types used to assess and optimize the sequences. Similarly, the covert trafficking
sequences found within opsins may not function equally well in all cell types. As a concrete
example, the H. salinarum bacteriorhodopsin has long been considered a difficult protein to
express in E. colil05, but it expresses readily in mammalian neurons, and can mediate
biologically meaningful photocurrents*0 . Similarly, channelrhodopsin-2 does not express well in
E. coli, but expresses well in mammalian neurons. Conversely, proteorhodopsins from
uncultured marine gamma-proteobacteria express and function well in E.coli, but do not generate
photocurrents in HEK293 cells or mouse neurons40, despite a rudimentary degree of expression
of the proteorhodopsin protein in these mammalian cells. Thus, reliance on a single heterologous
expression cell type (e.g., E. coli, yeast, Xenopus oocytes, HEK cells) as the sole testbed for
characterizing opsin physiological function, may lead to a partial picture of how well the opsins
assessed will perform across the broad set of cell targets confronted in biology. Similarly,
screening for enhancing mutations, trafficking sequences, or other beneficial modifications,
using a single heterologous expression cell type, may lead to unintentional optimization of the
opsin for function in that particular cell type, and potential deoptimization of expression,
trafficking, or function in other cell types of interest within the ultimate tool usage spectrum.
If mammalian neurons in the living mouse or rat are the target, then mammalian neurons in
primary culture should be at some point used to assess the function of a given opsin*0 ', although
ideally in vivo assessment should be performed as well, given the very different state of neurons
in vivo vs. in vitro. It is important to note that different types of neurons, at different ages, may
well differ in their level and timecourse of opsin expression and function. We typically utilize
mouse hippocampal and cortical primary cultures because they contain representatives of some
of the major cell classes in the brain'. However, primary neuron cultures are laborious to prepare
and maintain, and so we and others use HEK293 cell lines to perform electrophysiological
characterization of opsins40,92,106,93. HEK cells are more robust, and easier to work with, than
neurons, and can be grown for multiple cell division cycles in culture, unlike neuron cultures
which do not replicate after plating and differentiation. In addition, HEK cells possess cellular
shapes and molecular phenotypes that are somewhat less variable than those of neurons, and
possess fewer active conductances than do neurons; both of these features help reduce variability
of opsin characterization measurements. Conversely, HEK cells may yield smaller photocurrents
than do neurons due to their smaller surface area, and may have limited utility in fully predicting
how well a protein will traffic in neurons. As a simple example of this latter point, HEK cells do
not possess axons or dendrites; some findings have been published claiming that certain opsins
preferentially traffic to the synaptic processes of neurons'07, and any such effects would not be
observable in a IEK cell. However, HEK cells are still extremely useful for performing fast
screening assays of whether there is any physiological effect of illuminating a given opsin, and
may be particularly useful for characterization of amplitude-normalized features of opsins such
as the action spectrum, the plot of the relative photocurrent observed upon delivery of light of
different colors.
Transfection is the simplest and fastest way to get DNA that encodes for opsins into cells, for
rapid characterization of opsins in a cellular context For HEK cells, transfection can increase
the likelihood of delamination from the substrate; the use of Matrigel to promote cell adhesion to
a glass coverslip when plating, as opposed to poly-lysine, is suggested. Well-dissociated HEK
cells that are spatially separated from one another are critical for high-quality
electrophysiological assays, as HEK cells that grow together can form gap junction-connected
syncytia that can preclude accurate electrophysiological analysis of expressed opsins, by
compromising voltage-clamp fidelity. In order to improve the quality of HEK cells for
physiological assessment, passage the cells for their final plating when they reach medium levels
of confluence (~50%); then, during the fmal plating step, trypsinize the HEK cells, resuspend the
cells in serum-free media and pipette the cells against the sidewalls of the dish or flask to break
up clumps of cells, perhaps triturating the cells with a fine-gauged sterile needle (e.g., <5 times
to avoid excessive mechanical force on cells, through a -31 gauge needle), and then add serum-
containing media (to halt the trypsinization) before plating the final mixture on glass coverslips.
For neuron culture, mouse or rat hippocampal or cortical neurons should be cultured from PO
pups or E18 embryos at moderate densities, using standard protocols 40. Multiple experimenters
in our laboratory have independently found that the best recordings from opsin-expressing
neurons are often from ones in areas of sparse neuron density, often at the edge of the area
occupied by cells. The preferred method for HEK and neuron culture transfection is calcium
phosphate precipitation of DNA, e.g. using commercially available kits. The calcium phosphate
precipitation-based process can be harsh on neurons; accordingly, precautions should be taken.
The best transfection rates in neurons, in our hands, are achieved when neurons are transfected 3-
4 days in vitro, with rapidly diminishing efficiency beyond then (although the genes encoding for
quickly and highly expressed proteins, like Arch, can be delivered at 5 days in vitro).
Viral vectors can also be useful for assessing opsin function, because they can result in a high
yield of opsin-expressing cells in a cultured cell environment, and they can also be used to insure
a precise gene dosage into a cell of interest. They present lower neuron toxicity at a higher
cellular yield than can commonly be achieved with calcium phosphate transfection. One key
consideration is that recombination can be a major issue when preparing viral vectors, due to the
presence of repetitive sequences within the genomic vector of the virus, i.e. the payload-
encoding plasmid. In theory any E. coli with loss of function mutation in rec gene(s) should be
suitable for growing up such plasmids. However in our experience working with lentiviral
plasmids, Stbl3 (recA13-) E. coli have a much lower rate of recombination compared to other
rec- cells such as XL1-Blue (recAl-). XL10-Gold E. coli may work as well, with AAV
plasmids. It is recommended to try out different types of rec- cells to find the optimal one for a
particular viral vector, as recombination events can cause loss of vectors, and require time-
consuming plasmid reconstruction. It is also important to check if any special considerations are
needed for utilizing these specialized viral plasmid-optimized competent cell lines. For example
Stbl3 is endA+, and thus the endA endonuclease will need to be removed with appropriate
washing when purifying the DNA, to prevent DNA degradation. To check for recombination,
viral plasmids should regularly be verified in both sequence and topology, using DNA
sequencing and restriction digestion respectively. Both methods are recommended because
sequencing short regions, such as the cloned insert, will only inform whether the sequence is
locally correct, while recombination can occur between unpredictable locations, so that the
cloned sequence is largely locally correct but different in global topology. Therefore it is highly
recommended to perform multiple restriction digests to verify that the global sequence topology
has not deviated from the designed plasmid. When cloning payloads into viral vectors, it is
important to use only parent vectors that have also been tested for recombination, and it is
important to perform both sequencing and restriction digests periodically as a viral plasmid stock
is generated and propagated, ideally minimizing the number of generations that a stock is
propagated to the minimum possible.
4.3 Physiological assays
Once a molecule is chosen, and expressed in a target cell type for characterization, it must be
physiologically characterized by an observation method (e.g., patch clamp, dye imaging) - in the
case of opsins, using illumination. Below we discuss illumination hardware, solutions in which
to perform experiments, strategies for selecting cells to be analyzed, and methods for cellular
readout.
The millisecond-scale resolution of optogenetic tools enables the remote control of cellular
physiology with unprecedented resolution, but also requires illumination sources with increased
temporal resolution than what is achievable with conventional fluorescence illuminators. A
commonly used programmable excitation source is the Sutter DG-4, which uses a galvanometer
mirror to direct light from the lamp into one of four filter slots within the lamp in order to
determine the excitation wavelength. A second mirror is used to shutter and/or adjust the
intensity of light by modulating how much is directed to the light collection optics for delivery
from the DG4 into the microscope. The output of the DG4 can be fed into an illuminator port of
practically any microscope used for fluorescence imaging or electrophysiology. Laser based
systems are also useful; since the action spectra of microbial rhodopsins are quite broad,
typically with 100-150 nm bandwidths (full-width at half-maximum), sub-optimal excitation at a
given wavelength of illumination can easily be compensated for by increased illumination
power. For example, a 532 nm solid-state green laser is an order of magnitude cheaper than a
593 nm solid-state yellow laser, but will still excite the yellow light-sensitive N. pharaonis
halorhodopsin quite effectively, just by increasing the delivered power slightly over the amount
that would be required if a 593 nm laser were used. Action spectra (but not true absorbance
spectra, which requires flash photolysis) can be measured during electrophysiological recording,
by scanning through the visual spectrum with a Till Photonics Polychrome V or analogous color-
programmable light source, coupled to a microscope through a standard fiber optic cable. In this
particular illuminator, broadband light from a xenon lamp is passed through a programmable
monochromator, so as to emit light with narrowband (10 nm bandwidths) properties, centered at
various wavelengths. Light-emitting diodes (LEDs) have become increasingly popular due to
their cheapness and fast switching times; a recent report 08 offers excellent instructions for
constructing a high-power and fast illuminator with two LEDs co-aligned for dual-spectral
excitation, and commercial systems from Thorlabs and other vendors are also available. Most
LEDs can be switched on and off with very fast (e.g., nanosecond) resolution, so the temporal
resolution of various LED systems is largely limited by the drivers or power sources. LEDs are
particularly useful for ultraviolet, orange, red, and infrared wavelengths, since many lamps are
only weakly irradiant in these spectral bands.
Solutions used in electrophysiological characterization of mammalian cells (e.g., during patch
clamp or imaging) are in some ways more complicated than typical solutions used in molecular
biology. We highly suggest preparing electrophysiology solutions from scratch, instead of
purchasing pre-made solutions. These solutions must be osmotically balanced to prevent cell
death, ideally within 1-5 mOsm, and pH balanced, ideally within 0.1 pH units; extreme
precaution must be taken to avoid contamination of reagents (as even a small change in a low-
concentration ion, like calcium, can greatly change the health or electrical properties of a cell
under electrophysiological study). For example, our laboratory (and many other
electrophysiology laboratories) avoid insertion of spatulas into stock containers to dispense
solids for preparing electrophysiological solutions; chemicals are instead poured from stock
containers whenever possible. Solutions should be sterile filtered immediately following
preparation, to maximize cell health and available recording time, as use of sterile aliquots of
solutions can improve cell health. Our bath solution of choice for in vitro experiments using
both HEK cells and neurons is Tyrode's solution, a HEPES buffer-based saline solution'.
Artificial cerebrospinal fluid (ACSF), which is bicarbonate-buffered, may improve cell health in
certain circumstances over that obtained from use of Tyrode's Solution, but requires fluid
manifolds to perfuse CO2-saturated solutions in order to maintain physiological pH levels, and
the added inconvenience is often not justified. For the use of dyes that indicate the levels of ions
such as H* or Ca2+ (e.g., SNARF, fura-2, Oregon Green BAPTA), the manufacturers'
instructions provide a good starting point for deriving protocols for the loading and imaging of
the dyes, although some optimization of loading conditions and imaging conditions may be
required for given cell types and given conditions ofjoint photostimulation and imaging40 92 0 9.
Even within a cell type, different cells will vary in their levels of opsin expression, appearance,
and sustained photocurrents, potentially to great degrees. Excessive overexpression of an opsin
can lead to poor cell health, so simply picking the very brightest cells to record
electrophysiologically may yield unrepresentative data, and accurate characterization of the
performance of an opsin ideally is performed with unbiased selection of cells. Beginning
experimenters may have slightly different, even unconscious, biases in cell choice strategy, e.g.
choosing the biggest cells in the field of view. To address some of these problems, we often
normalize observed photocurrents by cell capacitance, thus obtaining the photocurrent density,
which helps compensate for the varying size of the cells being recorded.
Expression of opsins in a cell can increase over time, as the process of protein expression and
trafficking can be slow. For full characterization of an opsin, it is recommended to assess opsin
function at various times after transfection, e.g. between a few days and a few weeks, to
understand the timecourse of expression and trafficking. Importantly, different opsins, and
opsins expressed using different gene delivery mechanisms, will present with different
timecourses of functional expression. In neurons, we have noted a trend for many microbial
rhodopsins from archaea to express and traffic to the membrane more quickly than do those from
fungus and plants, although specific opsins within these families can violate this trend.
Typically, the photocurrents measured in neurons from archaeal rhodopsins (both
bacteriorhodopsins and halorhodopsins) using the protocols in Section IV do not change after 5-6
days post-transfection or 10 days post-viral infection; photocurrents of channelrhodopsin-2 take
a few extra days to plateau, compared to the archaeal opsins. These are the times that it takes for
currents to saturate; fluorescence levels may saturate much earlier, perhaps because although
opsins are rapidly expressed at the level of protein, it may take some time for them to traffic, and
assemble within the membrane in functional form (e.g., some may potentially require
multimerization within the membrane to attain full function). It is possible that adding
trafficking sequences, or inducing mutations, can result in slowed down or sped up functional
protein expression, versus the wild type form of the opsin.
Similar trends in expression and membrane localization rates as a function of kingdom of origin
area also observed in transfected HEK cells, with faithful expression of rhodopsins from archaea
requiring two days and ones from fungi and plants requiring up to three days (although again,
individual opsins may violate these rules of thumb). These multi-day expression times may
present difficulties because HEK cells will divide a few times during this period, and this
counteracts the goal of performing reliable recordings on isolated cells (or on cells with minimal
shared membrane with other cells, as described in Section III). The addition of sodium
butyrate"0 or lowering the cell culture incubator temperature (32*C instead of 37*C) can extend
the time between cell divisions and allow for more time for membrane expression93.
4.4 Conclusion
The process of assessing the physiological function of a heterologously expressed protein in a
target cell is complex. Such explorations are critical for understanding the potential uses of a
given synthetic physiology tool, for evaluating potential side effects or toxicity of a candidate
tool, or for screening for novel or optimized tools. As a closing example, it was originally
believed that channelrhodopsin-1 (ChR1) was a light-gated proton channel, but multiple reports
since then have demonstrated that it is indeed a nonspecific cation channel like ChR2 when
evaluated at neutral pH and expressed at sufficiently high levels9 '"" . Thus, considerations of the
cellular environment in which a protein is evaluated, e.g. pH and expression level, are key for
understanding the physiological power of a given molecular tool. In summary, assessing the
function of a given physiological driver is complex because of the many variables that can
modulate the expression and performance of physiological drivers, and the quantitative, high-
speed nature of the signal being driven. The creation of new model systems that can replicate
key features of targeted physiological systems, in a fashion that could support high-throughput
tool assessment or tool optimization, may greatly enhance the ability to generate novel and
impactful synthetic physiology tools.
5. Summary and Further Work
The life and operation of cells involve physiological processes that take place over fast
timescales of milliseconds to minutes. Technologies for driving or suppressing specific fast
physiological processes in intact cells are critical for the ability to understand how those
physiological processes contribute to emergent cellular and organismal functions and behaviors.
Understanding and engineering optogenetic tools requires thinking and working at the level of
protein structure and dynamics.
A diversity of molecular tools have been developed which enable the precision control of neural
processes. We here present three novel optical silencers identified through an exploration of
phylogenetic diversity. Arch, Mac, and ArchT enable the powerful optically-mediated silencing
of the in vivo mammalian brain, as well as the multiple-color control of independent neuron
populations.
For the future, the identification of opsins which possess blue or red shifted action spectra would
be of great use to the neuroscience community. Opsins with spectrally distant action spectrum
enable the bidirectional control of single cell types, or the multiple color control of independent
cell populations with a minimum of cross-excitation. Additionally, a major barrier to in vivo
silencing is the light power attenuation created by tissue and hemoglobin optical absorption.
This optical attenuation is dramatically reduced at red wavelengths, suggesting that red light is
able to propagate further in the brain than other wavelengths, and thus enable the silencing of
much larger brain volumes. Thus, the engineering of optical hyperpolarizers may enable the
long-distance and less invasive inactivation of neural activity in the mammalian brain and is at
present an area of great interest.
6. Experimental Methods
6.1 Plasmid construction and site directed mutagenesis.
Opsins were mammalian codon-optimized, and synthesized by Genscript (Genscript Corp., NJ).
Opsins were fused in frame, without stop codons, ahead of GFP (using BamHI and AgeI) in a
lentiviral vector containing the CaMKII promoter, enabling direct neuron transfection, HEK cell
transfection (expression in HEK cells is enabled by a ubiquitous promoter upstream of the
lentiviral cassette), and lentivirus production (except for Halobacterium salinarum halorhodopsin,
which was fused to GFP in the vector pEGFP-N3 (using EcoRI and BamHI) and only tested by
transfection). eNpHR was synthesized as described before, by inserting the signaling sequence
from the acetycholine receptor beta subunit (amino acid sequence: MRGTPLLLVVSLFSLLQD;
DNA sequence: atgaggggtacgcccctgctcctcgtcgtctctctgttetctctgcttcaggac) at the N-terminus, and
the ER2 sequence (amino acid sequence: FCYENEV; DNA sequence: ttctgctacgagaatgaagtg) at
the C-terminus of Halo.
The 'ss' signal sequence from truncated MHC class I antigen corresponded to amino acid
sequence (M)VPCTLLLLLAAALAPTQTRA, DNA sequence
GTCCCGTGCACGCTGCTCCTGCTGTTGGCAGCCGCCCTGGCTCCGACTCAGACGCGG
GCC. The 'Prl' Prolactin signal sequence corresponded to amino acid sequence
MDSKGSSQKGSRLLLLLVVSNLLLCQVVS, DNA sequence
gacagcaaaggttcgtcgcagaaagggtcccgcctgctcctgtgctggtggtgtcaaatctactcttgtgccagggtgtggttccacccc
cgtc. Halo point mutants for HEK cell testing were generated using the QuikChange kit
(Stratagene) on the Halo-GFP fusion gene inserted between BamHI and EcoRI sites in the
pcDNA3.1 backbone (Invitrogen). All constructs were verified by sequencing, and codon-
optimized sequences of key opsins were submitted to Genbank (mammalian codon-optimized
Arch, GU045593; mammalian codon-optimized Arch fused to GFP, GU045594; mammalian
codon-optimized Mac, GU045595; mammalian codon-optimized Mac fused to GFP, GU045596;
ss-Prl-Arch, GU045597; ss-Arch-GFP-ER2, GU045598; ss-Prl-Arch-GFP, GU045599) and
made available for request at:
http://syntheticneurobiology.org/protocols
The amino acid sequence of Halo is:
MTETLPPVTESAVALQAEVTQRELFEFVLNDPLLASSLYINIALAGLSILLFVFMTRGLDD
PRAKLIAVSTILVPVVSIASYTGLASGLTISVLEMPAGHFAEGSSVMLGGEEVDGVVTM
WGRYLTWALSTPMILLALGLLAGSNATKLFTAITFDIAMCVTGLAAALTTSSHLMRWF
WYAISCACFLVVLYILLVEWAQDAKAAGTADMFNTLKLLTVVMWLGYPIVWALGVEG
IAVLPVGVTSWGYSFLDIVAKYIFAFLLLNYLTSNESVVSGSILDVPSASGTPADD.
The amino acid sequence of Arch is:
MDPIALQAGYDLLGDGRPETLWLGIGTLLMLIGTFYFLVRGWGVTDKDAREYYAVTIL
VPGIASAAYLSMFFGIGLTEVTVGGEMLDIYYARYADWLFTTPLLLLDLALLAKVDRVT
IGTLVGVDALMIVTGLIGALSHTAIARYSWWLFSTICMIVLYFLATSLRSAAKERGPEV
ASTFNTLTALVLVLWTAYPILWIIGTEGAGVVGLGIETLLFMVLDVTAKVGFGFILLRSR
AILGDTEAPEPSAGADVSAAD.
The amino acid sequence of ArchT is:
MDPIALQAGYDLLGDGRPETLWLGIGTLLMLIGTFYFIVKGWGVTDKEAREYYSITILVP
GIASAAYLSMFFGIGLTEVTVAGEVLDIYYARYADWLFTTPLLLLDLALLAKVDRVSIGT
LVGVDALMIVTGLIGALSHTPLARYSWWLFSTICMIVVLYFLATSLRAAAKERGPEVAS
TFNTLTALVLVLWTAYPILWIGTEGAGVVGLGIETLLFMVLDVTAKVGFGFILLRSRAIL
GDTEAPEP.
The amino acid sequence of Mac is:
MIVDQFEEVLMKTSQLFPLPTATQSAQPTHVAPVPTVLPDTPIYETVGDSGSKTLWVVF
VLMLIASAAFTALSWKIPVNRRLYHVITTIITLTAALSYFAMATGHGVALNKIVIRTQHD
HVPDTYETVYRQVYYARYIDWAITTPLLLLDLGLLAGMSGAIFMAIVADLIMVLTGLF
AAFGSEGTPQKWGWYTIACIAYIVVWHLVLNGGANARVKGEKLRSFFVAIGAYTLIL
WTAYPIVWGLADGARKIGVDGEIIAYAVLDVLAKGVFGAWLLVTHANLRESDVELNGF
WANGLNREGAIRIGEDDGA.
6.2 Neuron culture, transfection, infection, and imaging
All procedures involving animals were in accordance with the National Institutes of Health
Guide for the care and use of laboratory animals and approved by the Massachusetts Institute of
Technology Animal Care and Use Committee. Swiss Webster or C57 mice (Taconic or Jackson
Labs) were used. For hippocampal cultures, hippocampal regions of postnatal day 0 or day 1
mice were isolated and digested with trypsin (1 mg/ml) for ~12 min, and then treated with Hanks
solution supplemented with 10-20% fetal bovine serum and trypsin inhibitor (Sigma). Tissue
was then mechanically dissociated with Pasteur pipettes, and centrifuged at 1000 rpm at 4*C for
10 min. Dissociated neurons were plated at a density of approximately four hippocampi per 20
glass coverslips, coated with Matrigel (BD Biosciences). For cortical cultures, dissociated
mouse cortical neurons (postnatal day 0 or 1) were prepared as previously described, and plated
at a density of 100-200k per glass coverslip coated with Matrigel (BD Biosciences). Cultures
were maintained in Neurobasal Medium supplemented with B27 (Invitrogen) and glutamine.
Hippocampal and cortical cultures were used interchangeably; no differences in reagent
performance were noted.
Neurons were transfected at 3-5 days in vitro using calcium phosphate (Invitrogen). GFP
fluorescence was used to identify successfully transfected neurons. Alternatively, neurons were
infected with 0.1-1 pl of lentivirus per well at 3-5 days in vitro. Throughout the paper, neurons
were transfected unless indicated as having been infected. All images and electrophysiological
recordings were made on neurons 9-14 days in vitro (approximately 6-10 days after transfection
or viral infection).
Confocal images of infected neurons in culture (briefly fixed in 4% paraformaldehyde) were
obtained with a Zeiss LSM 510 confocal microscope (63X magnification objective lens).
Culture images were maximum intensity projections made from sets of 5 images (1.0 pm image
plane thickness) spaced along the z-axis by 0.5 micron steps. Quantitative confocal analysis of
membrane expression of opsins was performed using infected neurons in culture (10 days post-
infection, briefly fixed in 4% paraformaldehyde). Images were obtained with a Zeiss LSM 510
confocal microscope (63X magnification objective lens), always with the same illumination and
observation parameters to avoid procedural variability. Given the near-100% viral infection rate,
isolated neurons were chosen for analysis in order to reduce background fluorescence from
nearby neurons and their processes. Images were analyzed in ImageJ (National Institutes of
Health), based on a neuron-adapted version of a previously reported algorithm used to assay
membrane expression of channelrhodopsins and channelrhodopsin variants in HEK cells. An
image was first filtered with a 2-pixel Gaussian blur, and the filtered image was subtracted from
the original one to enhance the contour of the cell.
6.3 HEK 293FT cell culture and transfection
HEK 293FT cells (Invitrogen) were maintained between 10-70% confluence in D10 medium
(Cellgro) supplemented with 10% fetal bovine serum (Invitrogen), 1% penicillin/streptomycin
(Cellgro), and 1% sodium pyruvate (Biowhittaker)). For recording, cells were plated at 5-20%
confluence on glass coverslips coated with Matrigel (BD Biosciences). Adherent cells were
transfected approximately 24 hours post-plating either with TransLT 293 lipofectamine
transfection kits (Mirus) or with calcium phosphate transfection kits (Invitrogen), and recorded
via whole-cell patch clamp between 36-72 hours post-transfection.
6.4 Lentivirus preparation
HEK293FT cells (Invitrogen) were transfected with the lentiviral plasmid, the viral helper
plasmid pA8.74, and the pseudotyping plasmid pMD2.G. The supernatant of transfected HEK
cells containing virus was then collected 48 hours after transfection, purified, and then pelleted
through ultracentrifugation. Lentivirus pellet was resuspended in phosphate buffered saline
(PBS) and stored at -800C until further usage in vitro or in vivo. The estimated final titer is
approximately 109 infectious units/mL.
6.5 Virus injection in the adult mouse.
All procedures were in accordance with the National Institutes of Health Guide for the Care and
Use of Laboratory Animals and approved by the Massachusetts Institute of Technology
Committee on Animal Care. Under isoflurane anesthesia, 1 pL lentivirus was injected through a
craniotomy made in the mouse skull, into the motor cortex (0.62 mm anterior, 0.5 mm lateral,
and 0.5 mm deep, relative to bregma), or the sensory cortex (0.02 mm posterior, 3.2 mm lateral,
and 2.2 mm deep, relative to bregma). Virus was injected at a rate of 0.1-0.2 plmin through a
cannula connected via polyethylene tubing to a Hamilton syringe, placed in a syringe pump
(Harvard Apparatus). The syringe, tubing, and cannula were filled with silicone oil (Sigma).
For mice used for in vivo recordings, custom-fabricated plastic headplates were affixed to the
skull, and the craniotomy was protected with agar and dental acrylic.
6.6 In vitro whole cell patch clamp recording & optical stimulation
Whole cell patch clamp recordings were made using a Multiclamp 700B amplifier, a Digidata
1440 digitizer, and a PC running pClamp (Molecular Devices). Neurons were bathed in room
temperature Tyrode containing 125 mM NaCl, 2 mM KCl, 3 mM CaCl2, 1 mM MgCl 2, 10 mM
HEPES, 30 mM glucose, 0.01 mM NBQX and 0.01 mM GABAzine. The Tyrode pH was
adjusted to 7.3 with NaOH and the osmolarity was adjusted to 300 mOsm with sucrose. HEK
cells were bathed in a Tyrode bath solution identical to that for neurons, but lacking GABAzine
and NBQX. Borosilicate glass pipettes (Warner Instruments) with an outer diameter of 1.2 mm
and a wall thickness of 0.255 mm were pulled to a resistance of 3-9 Mfl with a P-97
Flaming/Brown micropipette puller (Sutter Instruments) and filled with a solution containing 125
mM K-gluconate, 8 mM NaCl, 0.1 mM CaCl 2, 0.6 mM MgCI2, 1 mM EGTA, 10 mM HEPES, 4
mM Mg-ATP, and 0.4 mM Na-GTP. The pipette solution pH was adjusted to 7.3 with KOH and
the osmolarity was adjusted to 298 mOsm with sucrose. Access resistance was 5-30 M9,
monitored throughout the voltage-clamp recording. Resting membrane potential was ~-60 mV
for neurons and ~-30 mV for HEK 293FT cells in current-clamp recording.
Photocurrents were measured with 500 ms light pulses in neurons voltage-clamped at -60 mV,
and in HEK 293FT cells voltage-clamped at -30 mV. Light-induced membrane
hyperpolarizations were measured with 500 ms light pulses in cells current-clamped at their
resting membrane potential. Light pulses for all wavelengths except 660 nm and action spectrum
characterization experiments were delivered with a DG-4 optical switch with 300 W xenon lamp
(Sutter Instruments), controlled via TTL pulses generated through a Digidata signal generator.
Green light was delivered with a 575 ±25 nm bandpass filter (Chroma) and a 575 ± 7.5 nm
bandpass filter (Chroma). Action spectra were taken with a Till Photonics Polychrome V, 150 W
Xenon lamp, 15 nm monochromator bandwidth.
Data was analyzed using Clampfit (Molecular Devices) and MATLAB (Mathworks, Inc.)
6.7 In vivo rodent electrophysiology, optical stimulation, and data analysis.
Recordings were made in the cortex of headfixed awake mice 1-2 months after virus injection,
using glass microelectrodes of 5-20 MA impedance filled with PBS, containing silver/silver-
chloride wire electrodes. Signals were amplified with a Multiclamp 700B amplifier and digitized
with a Digidata 1440, using pClamp software (Molecular Devices). A 50 mW yellow laser
(SDL-593-050T, Shanghai Dream Laser) was coupled to a 200 micron-diameter optical fiber.
The laser was controlled via TTL pulses generated through Digidata. Laser light power was
measured with an 818-SL photodetector (Newport Co.). An optical fiber was attached to the
recording glass electrode, with the tip of the fiber -600 pm laterally away from and ~500 pm
above the tip of the electrode (e.g., ~800 microns from the tip), and guided into the brain with a
Siskiyou manipulator at a slow rate of 1.5 pm/s to minimize deformation of the cortical surface.
Data was analyzed using MATLAB (Mathworks, Inc.). Spikes were detected and sorted offline
using Waveclus (http://vis.caltech.edu/rodri/Waveclus/Waveclushome.htm). Neurons
suppressed during light were identified by performing a paired t-test, for each neuron, between
the baseline firing rate during the 5 second period before light onset vs. during the period of 5
second light illumination, across all trials for that neuron, thresholding at the p < 0.05
significance level. Instantaneous firing rate histograms were computed by averaging the
instantaneous firing rate for each neuron, across all trials, with a histogram time bin of 20 ms
duration. To determine the latency between light onset and the neural response, we swept a 20
ms-long sliding window through the electrophysiology data and looked for the earliest 20 ms
period that deviated from baseline firing rate, as assessed by performing a paired t-test for the
firing rate during each window vs. during the baseline period, across all trials for each neuron.
Latency was defined as the time from light onset to the time at which firing rate was significantly
different from baseline for the following 120 ms. The time for after-light suppression to recover
back to baseline was calculated similarly.
6.8 In vivo primate electrophysiology, optical stimulation, and data analysis.
Primate virus injection and general surgical procedures were as previously described 4. One
rhesus monkey (Macaca mulatta), 12 years of age, weighing ~15 kg, was used. All procedures
were in accordance with the National Institutes of Health Guide for the care and use of
Laboratory Animals and approved by the Massachusetts Institute of Technology Animal Care
and Use Committee. Under isoflurane anesthesia, a titanium headpost and recording chambers
were surgically affixed to the skull, and a craniotomy was opened up in the chamber on the
parietal region. Lentivirus was injected at a rate of 0.1-0.2 ml/min at multiple depths depending
on the cortex geometry. The angle of the injection was stereotactically vertical.
Primate optical stimulation and electrophysiological recording. A 100 mW green laser (SDL-
532-100T, Shanghai Dream Laser Co.) was coupled to a 200 micron-diameter optical fiber
(FIBER-200-UV, Ocean Optics) through a homebuilt collimator setup as described 74, resulting in
a fiber tip irradiance of 100-200 mW/mm2. The laser was controlled via TTL pulses driven by a
pulse generator (DS8000, WPI Inc.) with the timing controlled by a computer through the
software package, Cortex (http://www.cortex.salk.edu/). Standard tungsten electrodes of 1-2
MK resistance (FHC, Inc.) were guided into the brain along with a fiber attached to the electrode
with the tip of the fiber slight above the tip of the electrode, typically 300-500 mm.
Data amplification, filtering and acquisition were performed with a Multichannel Acquisition
Processor (MAP) system (Plexon, Inc.). Spikes sampled at 40 kHz and filtered as 250 Hz -8
kHz were semi-automatically detected using an interactively-set threshold, and the spike
waveforms were offline sorted using principal component analysis (PCA) (Offline Sorter,
Plexon, Inc.). Most of the neurons recorded had broad spike waveforms with trough-to-peak
duration >200 ps (6 out of 45 single neurons had trough-to-peak waveform durations of 100-200
ps, suggestive of non-excitatory neurons), indicating that most of the recorded neurons (39/45)
were putative excitatory neurons (Mitchell et al., 2007). Spike timing was defined as the moment
of threshold crossing. During the experiment, one fiber and one electrode were lowered into the
brain of an awake headfixed monkey, and optical stimulation was performed while units were
recorded. During the recording period, the monkeys were awake and freely viewing, in a dimly
lit room. Occasional juice rewards were delivered to insure alertness, but no tasks nor reward
contingencies were scheduled in recording sessions.
6.9 Histology
Infected HEK cells and neurons in culture were fixed in 4% paraformaldehyde and mounted in
Vectashield Mounting Media (Vector Labs). Mice were perfused through the left cardiac
ventricle with 4% paraformaldehyde in PBS. The brain was removed and sectioned into 40-150
um coronal sections on a cryostat. Brain sections were mounted with Vectashield HardSet
(Vector Labs). Slides were visualized and imaged with a Leica DM16000 B inverted microscope
using lOx, 20x, and 40x objective lenses, and a Zeiss LSM 510 confocal microscope using 20x
and 63x objective lenses.
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